SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today ...
PHILADELPHIA, March 18, 2026--(BUSINESS WIRE)--iECURE, Inc., a clinical-stage genome editing company developing variant-agnostic in vivo targeted gene insertion therapies for the treatment of severe, ...
Chemistry, manufacturing, and controls (CMC) is key in drug development, ensuring novel therapeutics’ consistency, quality, and safety. The approval process for new medications can take 10–15 years, ...
Current Regenerative Medicine Advanced Therapy (RMAT) designation and CDRP participation provide opportunity for expedited regulatory pathway and advancement of FT819 Phase 2 potentially ...
Officials from the US Food and Drug Administration (FDA) and representatives from the pharmaceutical industry shared insights on the agency’s Chemistry, Manufacturing, and Controls (CMC) Development ...
Starting April 1, 2023, the U.S. Food and Drug Administration (FDA) will begin accepting requests to participate in a new Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot ...
If a recent decision of a CIRA panel under the CIRA Domain Name Dispute and Resolution Policy is followed, the ability of trademark owners to establish 'rights' in a trademark sufficient to succeed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results